Eliza Hayes Bakken says the bivalent booster supply for children has been “stop and go” for clinics. “We quickly saw that the demand for that vaccine outstripped our ability to keep it in stock."

Arcutis Therapeutics announces positive results in a Phase 3 trial of a new treatment for mild to moderate atopic dermatitis. Eric Simpson, M.D., says, “Atopic dermatitis is a chronic and burdensome disease, especially common with children, that has a significant need for rapid-acting topical treatment options outside of corticosteroids, which aren’t suitable for long-term care due to local side effects, safety concerns, and potential for rebound or withdrawal.

The OHSU School of Nursing’s new Oregon Nurse Education Academy will prepare experienced nurses to become clinical faculty and preceptors who support the education of new nurses and nursing students. Joanne Noone, Ph.D., RN, ANEF, FAAN, says: “As we work to increase the number of working nurses to meet growing patient care needs, we also need to increase the number of nurse educators who help new and future nurses excel as nursing professionals.”

Researchers at OHSU collaborate on new research from Oregon State University producing nanoparticles capable of treating cancer lesions.

Medscape covers new research that found babies born to women who experience preeclampsia are roughly a third more likely to develop cardiovascular disease later in life. Kent Thornburg, Ph.D., says these babies “need to be followed for cardiovascular risk for the rest of their life.”

Every year about 1,000 new cases of osteosarcoma are diagnosed in the U.S., and nearly half of these are in children and teens. Katrina Winsnes, M.D., explains why this population is so heavily affected.

Through a training program at Oregon Health & Science University, hundreds of dental professionals nationwide are learning how to better understand issues with substance use disorder and how they can be addressed.

An OHSU School of Dentistry training helps dental professionals safely manage their patients’ pain while also helping curb the national opioid epidemic. The training includes information on the Prescription Drug Monitoring Program, which Karan Replogle, D.D.S., M.S., says allows her as a dentist to “have a conversation with any patient about their pain, how they're currently managing pain, and how that may affect any pain medication that I need to prescribe to them as a dentist for a dental procedure."

OPB reports that bivalent vaccine boosters for children are hard to find in Oregon. Eliza Hayes Bakken, M.D., says, “We quickly saw that the demand for that vaccine outstripped our ability to keep it in stock.”

However, not long after Ariella was admitted to the hospital, she was transferred to Oregon Health & Science University Doernbecher Children's Hospital in Portland, where she is currently in the pediatric intensive care unit.